| AFATINIB |
210804 |
001 |
ANDA |
AFATINIB |
TABLET;ORAL |
20MG |
No
|
No
|
2023/02/14
(TA)
|
--
|
MSN PHARMACEUTICALS INC |
None (Tentative Approval) |
| AFATINIB |
210804 |
002 |
ANDA |
AFATINIB |
TABLET;ORAL |
30MG |
No
|
No
|
2023/02/14
(TA)
|
--
|
MSN PHARMACEUTICALS INC |
None (Tentative Approval) |
| AFATINIB |
210804 |
003 |
ANDA |
AFATINIB |
TABLET;ORAL |
40MG |
No
|
No
|
2023/02/14
(TA)
|
--
|
MSN PHARMACEUTICALS INC |
None (Tentative Approval) |
| AFATINIB |
210703 |
002 |
ANDA |
AFATINIB |
TABLET |
30MG |
No
|
No
|
2026/01/09
(TA)
|
--
|
SANDOZ INC |
None (Tentative Approval) |
| AFATINIB |
210703 |
003 |
ANDA |
AFATINIB |
TABLET |
20MG |
No
|
No
|
2026/01/09
(TA)
|
--
|
SANDOZ INC |
None (Tentative Approval) |
| AFATINIB |
210703 |
004 |
ANDA |
AFATINIB |
TABLET |
40MG |
No
|
No
|
2026/01/09
(TA)
|
--
|
SANDOZ INC |
None (Tentative Approval) |